Evidence map›Paper›PMID 28406437›Full record

ReviewNutrients2017

Low Glycemic Index Prototype Isomaltulose-Update of Clinical Trials.

Constanze Christin Maresch, Sebastian Friedrich Petry, Stephan Theis, Anja Bosy-Westphal, Thomas Linn

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03652207 (The Effects of Palatinose™ on Weight Management and Body Composition in Overweight and Obese Individuals), which is not on this map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03652207 nacompletednot on this map

The Effects of Palatinose™ on Weight Management and Body Composition in Overweight and Obese Individuals

TypeinterventionalSponsorBeneo-InstituteRan2009 to 2010Enrolled64ConditionsOverweight and Obesity, Diet Modification, Body WeightArmsisomaltulose (Palatinose(TM), Sucrose
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Sustainable isomaltulose production inFrontiers in microbiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Constanze Christin MareschClinical Research Unit, Centre of Internal Medicine, Justus Liebig University, 35392 Giessen, Hesse, Germany. constanze.c.maresch@ernaehrung.uni-giessen.de.
Sebastian Friedrich PetryClinical Research Unit, Centre of Internal Medicine, Justus Liebig University, 35392 Giessen, Hesse, Germany. Sebastian.Petry@innere.med.uni-giessen.de.
Stephan TheisBENEO-Institute, 67283 Obrigheim/Pfalz, Germany. Stephan.Theis@beneo.com.
Anja Bosy-WestphalApplied Nutritional Science/Dietetics, University of Hohenheim, 70599 Stuttgart, Baden-Württemberg, Germany. Anja.Bosy-Westphal@uni-hohenheim.de.
Thomas LinnClinical Research Unit, Centre of Internal Medicine, Justus Liebig University, 35392 Giessen, Hesse, Germany. thomas.linn@innere.med.uni-giessen.de.
Justus-Liebig-Universität Gießen · DEUniversity of Hohenheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low glycemic index diets are supposed to achieve a more beneficial effect on blood glucose control in people with diabetes mellitus and may also provide metabolic benefits for the general population. A prototype of a low-glycemic index carbohydrate is the natural occurring disaccharide isomaltulose that can be commercially produced from sucrose (beet sugar) to industrial scale. It is currently used in various food and drink applications as well as special and clinical nutrition feeds and formula diet as a food ingredient and alternative sugar. Here we provide an overview on clinical trials with isomaltulose including an analysis of its effects on glycemia and fat oxidation as compared to high glycemic index sugars and carbohydrates. In addition, we discuss recent reports on beneficial effects in weight-loss maintenance and pregnancy.

Indexed as

Diet, DiabeticGlycemic IndexAthletic PerformanceBody Weight MaintenanceClinical Trials as TopicCognitionDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diet, ReducingFemaleHumansHyperglycemiaIsomaltoseMaleNutritive SweetenersOverweightIsomaltoseisomaltuloseNutritive Sweetenersclinical trialsdiabetes mellitusfertility and pregnancy outcomeglucose metabolismglycemic indexisomaltulosesweetened beveragesweight-loss maintenance

Identifiers

PMID28406437
PMCPMC5409720
OpenAlexW2605744918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.